| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 18.295 | 24.610 | 23.648 | 0 | 23.926 |
| Total Income - EUR | - | - | - | - | - | 27.412 | 27.862 | 25.292 | 0 | 31.403 |
| Total Expenses - EUR | - | - | - | - | - | 25.404 | 32.017 | 25.139 | 0 | 33.778 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.007 | -4.154 | 153 | 0 | -2.375 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.892 | -4.425 | -332 | 0 | -2.657 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 0 | 1 |
Check the financial reports for the company - Diagnoza Cojobest S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 11.905 | 9.574 | 7.960 | 0 | 7.835 |
| Current Assets | - | - | - | - | - | 6.860 | 16.995 | 43.587 | 0 | 76.617 |
| Inventories | - | - | - | - | - | 3.588 | 16.189 | 40.554 | 0 | 72.201 |
| Receivables | - | - | - | - | - | 0 | -73 | 1.336 | 0 | 747 |
| Cash | - | - | - | - | - | 3.272 | 879 | 1.698 | 0 | 3.669 |
| Shareholders Funds | - | - | - | - | - | 1.934 | -2.534 | -2.874 | 0 | -5.329 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 0 | 40 |
| Debts | - | - | - | - | - | 2.462 | 18.306 | 45.234 | 0 | 89.557 |
| Income in Advance | - | - | - | - | - | 14.368 | 10.798 | 9.188 | 0 | 225 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4520 - 4520" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Diagnoza Cojobest S.r.l.